Logo-jcvtr

J Cardiovasc Thorac Res. 2016;8(1): 34-39. doi: 10.15171/jcvtr.2016.06
PMID: 27069565        PMCID: PMC4827137

Original Article

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality

Leili Pourafkari 1,2, Ognjen Visnjevac 2, Samad Ghaffari 1, Nader D. Nader 2 *

Cited by CrossRef: 4


1- Kiziltunc E, Sabanoglu C, Felekoglu M, Eyerci N, Karayigit O, Ates O. Association between inflammation and cigarette smoking in cardiac remodeling after acute myocardial infarction. HVT. 2022;7(Issue 1):23 [Crossref]
2- Severino P, D'Amato A, Pucci M, Infusino F, Adamo F, Birtolo L, Netti L, Montefusco G, Chimenti C, Lavalle C, Maestrini V, Mancone M, Chilian W, Fedele F. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. IJMS. 2020;21(21):8118 [Crossref]
3- Wang C, Guo J, Di A, Zhu Y, Han W, Cheng A, Li C, Si R, Lan T, Zhang R, Liu H, Yan G, Severino P. The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury. Cardiology Research and Practice. 2021;2021:1 [Crossref]
4- Hu J, Yang C, Yang G, Du H, Zhao H, Liu H. Effects of atorvastatin doses on serum level of procalcitonin and predictors for major adverse cardiovascular events in patients with acute myocardial infarction: a pilot study and post hoc analysis. 2022;33(1):e87 [Crossref]